<?xml version="1.0" encoding="UTF-8"?>
<p>Blood can be transfused as “whole blood”, collected and stored in an anticoagulant. However, in order to satisfy the needs of more patients, blood can be divided into its parts, including red cell concentrate, fresh frozen plasma, cryoprecipitate and platelet concentrate. Some blood products have a short shelf life compared to others. The unavoidable delay between donation and the identification of a viraemic donor means that by the time the recall of components is initiated, the short shelf-life components may already be transfused. At best, longer shelf-life red cell and frozen components can be recalled [
 <xref rid="B62-medicina-56-00206" ref-type="bibr">62</xref>]. The virus is viable in the blood and blood products for a significant time. Colson et al. (2007) reported a case where the recipient developed hepatitis six weeks after transfusion of blood products. The virus remained viable in the blood for four weeks after collection [
 <xref rid="B63-medicina-56-00206" ref-type="bibr">63</xref>]. 
</p>
